HKG:6821 Market Cap

HKG:6821 has a market cap or net worth of 28.71 billion as of April 4, 2025. Its market cap has decreased by -28.35% in one year.

Market Cap

28.71B

Enterprise Value

20.97B

Revenue

6.18B

Ranking

n/a

PE Ratio

28.43

Stock Price

55.75

Market Cap Chart

Since November 18, 2016, HKG:6821's market cap has increased from 5.59B to 28.71B, an increase of 413.51%. That is a compound annual growth rate of 21.57%.

Market Cap History

Date	Market Cap	% Change
Apr 3, 2025	28.71B	2.82%
Dec 31, 2024	27.92B	-38.76%
Dec 29, 2023	45.59B	-23.48%
Dec 30, 2022	59.58B	-56.36%
Dec 31, 2021	136.53B	58.47%
Dec 31, 2020	86.15B	157.03%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
BeiGene	227.71B
Hansoh Pharmaceutical Group Company	145.09B
WuXi Biologics	109.81B
JD Health International	105.43B
Innovent Biologics	80.03B
Akeso	77.19B
Alibaba Health Information Technology	76.07B
Sichuan Kelun-Biotech Biopharmaceutical	70.00B

Market Cap Rankings